1. AB0388 Risk of Non Adherence To Oral Disease Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis. ARCO Study. (15th July 2016) Authors: Monteagudo, I.; Raya Alvarez, E.; Marras Fernandez-Cid, C.; Salvador Alarcόn, G.; Vázquez-Rodríguez, T.R.; Tovar Beltrán, J.V.; Escudero-Contreras, A.; Alegre-Sancho, J.J.; Ortiz García, A.M.; Olivé, A.; Cea-Calvo, L.; Arteaga, M.J.; Mestre, Y.; Calvo-Alén, J. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 1037 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0719 2-Year Incidence of New Immune-Mediated Inflamatory Diseases in Patients with Spondyloarthritis. the Aquiles Study. (10th June 2014) Authors: García-Vicuna, R.; Zarco, P.; Gonzalez, C.M.; Rodríguez de la Serna, A.; Peiro, E.; Mateo, I.; Linares, L.; Calvo, J.; Fernandez, S.; Cea-Calvo, L.; Arteaga, M.J.; Marín-Jiménez, I.; Vanaclocha, F. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 1041 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0829 Persistence on golimumab as second line biological therapy in patients with spondyloarthritis (AXIAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS). go-beyond, a retrospective study. (12th June 2018) Authors: González Fernández, C.M.; Alegre-Sancho, J.J.; García-Carazo, S.; Rodríguez-Heredia, J.M.; Bachiller-Corral, J.; Martín López, M.; Retuerto Guerrero, M.; Martín Santos, J.M.; Álvarez-Rivas, N.; Egües Dubuc, C.A.; Villa-Blanco, I.; Laiz, A.; Tovar Beltrán, J.V.; Beltrán, E.; Raya, E.; Ibáñez Bosch... Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1543 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0904 Prevalence of different immune-mediated inflammatory diseases in patients with spondyloarthropaties. Aquiles study. (23rd January 2014) Authors: García-Vicuña, R.; Zarco, P.; Rodríguez de la Serna, A.; Peirό, E.; Collantes, E.; Cea-Calvo, L.; Nadal, J.A.; Vanaclocha, F.; Marín-Jiménez, I.; González, C. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 690 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AB1004 Sources of Information Used by Patients with Rheumatic Diseases Treated with Subcutaneous Biological Therapy. Rheu-Life Survey. (15th July 2016) Authors: de Toro, F.J.; Batlle, E.; González, C.M.; Cea-Calvo, L.; Pérez-Calvo, M.A.; Carmona, L. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 1244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. AB1332 Factors associated to persistence on golimumab in patients with inflammatory arthritis of the biobadaser registry. (12th June 2018) Authors: Hernández, M.V.; Rodriguez, S.; Morlà, R.; Sánchez-Piedra, C.; Sánchez-Alonso, F.; Manero, F.J.; García-Magallón, B.; Pérez-Pampín, E.; Rodríguez-Lozano, C.; Ruiz, M.D.; Ortiz, A.; Díaz-Torné, C.; Mateo, L.; Gómez-Puerta, J.A.; Sanmartí, R.; Cea-Calvo, L.; Gómez-Reino, J.J. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1755 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. AB1470-HPR Beliefs and satisfaction with golimumab as second anti tnf-alpha of patients with spondyloarthritis. go-beyond. (12th June 2018) Authors: Juanola, X; González Fernández, C.M.; García-Carazo, S.; Rodríguez-Hereida, J.; Bachiller-Corral, J.; Martín López, M.; Retuerto Guerrero, M.; Martín Santos, J.; Álvarez-Rivas, N.; Egües Dubuc, C.; Villa-Blanco, I.; Laiz, A.; Tovar Beltrán, J.V.; Beltrán, E.; Raya, E.; Ibáñez Bosch, R.; Manero, J... Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1865 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. FRI0086 Is the discordance between the doctor and the patient a determinant of adherence?. (12th June 2018) Authors: Oton, T.; Calvo-Alén, J.; Cea-Calvo, L.; Carmona, L. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 588 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. FRI0290 FACTORS ASSOCIATED WITH PERSISTENCE OF GOLIMUMAB TREATMENT IN THE BIOBADASER REGISTRY, UP TO 7 YEARS OF FOLLOW-UP. (2nd June 2020) Authors: Pombo, M.; Sánchez-Piedra, C.; Cea-Calvo, L.; Manrique Arija, S.; Garcia-Magallon, B.; Campos Fernández, C.; Notario, I.; Diaz-Gonzalez, F.; Gomez-Reino, J. J. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 733 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. FRI0566 Attributes of The Subcutaneous Biologic Therapy Preferred by Patients with Rheumatic Disease and Satisfaction with The Treatment. RHEU LIFE Survey. (15th July 2016) Authors: González, C.M.; Carmona, L.; de Toro, F.J.; Arteaga, M.J.; Fernández, S.; Cea-Calvo, L.; Batlle, E. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 646 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗